Lowe, Richard F <br/><br/>
Rational design, synthesis, and structure-activity relationships of aryltriazoles as novel corticotropin-releasing factor-1 receptor antagonists.  [electronic resource] 

 -  Journal of medicinal chemistry  Mar 2005 
 - 1540-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0022-2623 
<br/><br/><label>Standard No.: </label>10.1021/jm049339c  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Blood-Brain Barrier--metabolism<br/>Cell Line<br/>Cyclic AMP--biosynthesis<br/>Drug Design<br/>Fibroblasts--metabolism<br/>Humans<br/>Male<br/>Mice<br/>Models, Molecular<br/>Molecular Conformation<br/>Radioligand Assay<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, Corticotropin-Releasing Hormone--antagonists & inhibitors<br/>Stereoisomerism<br/>Structure-Activity Relationship<br/>Triazoles--chemical synthesis<br/>CRF Receptor, Type 1